Deutsche Bank raised the firm’s price target on Iqvia (IQV) to $260 from $250 and keeps a Buy rating on the shares following the “solid” Q4 ...

Baird raised the firm’s price target on Iqvia (IQV) to $220 from $210 and keeps a Neutral rating on the shares. The firm updated its model ...

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Q4 2024 Management View CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency for the full year, excluding COVID-related revenues. Adjusted diluted EPS ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions. Surbhi Jain Elliott Investment Management Adds To Southwest, Western Digital ...

Maintaining that trust relies on IQVIA being a customer-centric organization, including anticipating industry needs and innovating new solutions to meet customer expectations that have transformed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Shlomo Rosenbaum; Analyst; ...

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia ...